272 related articles for article (PubMed ID: 14639613)
1. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.
Lukanova A; Zeleniuch-Jacquotte A; Lundin E; Micheli A; Arslan AA; Rinaldi S; Muti P; Lenner P; Koenig KL; Biessy C; Krogh V; Riboli E; Shore RE; Stattin P; Berrino F; Hallmans G; Toniolo P; Kaaks R
Int J Cancer; 2004 Jan; 108(2):262-8. PubMed ID: 14639613
[TBL] [Abstract][Full Text] [Related]
2. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
Kaaks R; Toniolo P; Akhmedkhanov A; Lukanova A; Biessy C; Dechaud H; Rinaldi S; Zeleniuch-Jacquotte A; Shore RE; Riboli E
J Natl Cancer Inst; 2000 Oct; 92(19):1592-600. PubMed ID: 11018095
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer.
Keinan-Boker L; Bueno De Mesquita HB; Kaaks R; Van Gils CH; Van Noord PA; Rinaldi S; Riboli E; Seidell JC; Grobbee DE; Peeters PH
Int J Cancer; 2003 Aug; 106(1):90-5. PubMed ID: 12794762
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study.
Lacey JV; Potischman N; Madigan MP; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Lurain JR; Fillmore CM; Sherman ME; Brinton LA
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):607-12. PubMed ID: 15066926
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.
Wei EK; Ma J; Pollak MN; Rifai N; Fuchs CS; Hankinson SE; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):850-5. PubMed ID: 15824155
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women.
Lukanova A; Toniolo P; Akhmedkhanov A; Biessy C; Haley NJ; Shore RE; Riboli E; Rinaldi S; Kaaks R
Int J Cancer; 2001 Jun; 92(6):888-92. PubMed ID: 11351312
[TBL] [Abstract][Full Text] [Related]
8. Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy).
Lukanova A; Lundin E; Micheli A; Akhmedkhanov A; Rinaldi S; Muti P; Lenner P; Biessy C; Krogh V; Riboli E; Hallmans G; Berrino F; Zeleniuch-Jacquotte A; Toniolo P; Kaaks R
Cancer Causes Control; 2003 Apr; 14(3):285-92. PubMed ID: 12814208
[TBL] [Abstract][Full Text] [Related]
9. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.
Oh JC; Wu W; Tortolero-Luna G; Broaddus R; Gershenson DM; Burke TW; Schmandt R; Lu KH
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):748-52. PubMed ID: 15159305
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
[TBL] [Abstract][Full Text] [Related]
11. Association between components of the insulin-like growth factor system and endometrial cancer risk.
Augustin LS; Dal Maso L; Franceschi S; Talamini R; Kendall CW; Jenkins DJ; Vidgen E; La Vecchia C
Oncology; 2004; 67(1):54-9. PubMed ID: 15459496
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition.
Cust AE; Allen NE; Rinaldi S; Dossus L; Friedenreich C; Olsen A; Tjønneland A; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Linseisen J; Chang-Claude J; Boeing H; Schulz M; Benetou V; Trichopoulou A; Trichopoulos D; Palli D; Berrino F; Tumino R; Mattiello A; Vineis P; Quirós JR; Agudo A; Sánchez MJ; Larrañaga N; Navarro C; Ardanaz E; Bueno-de-Mesquita HB; Peeters PH; van Gils CH; Bingham S; Khaw KT; Key T; Slimani N; Riboli E; Kaaks R
Int J Cancer; 2007 Jun; 120(12):2656-64. PubMed ID: 17285578
[TBL] [Abstract][Full Text] [Related]
13. Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study.
Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
Int J Cancer; 2007 May; 120(9):2007-12. PubMed ID: 17266031
[TBL] [Abstract][Full Text] [Related]
14. Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: comparison of endometrial cancer patients with healthy controls.
Rutanen EM; Stenman S; Blum W; Kärkkäinen T; Lehtovirta P; Stenman UH
J Clin Endocrinol Metab; 1993 Jul; 77(1):199-204. PubMed ID: 7686914
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of plasma C-peptide and colorectal cancer risk in men.
Ma J; Giovannucci E; Pollak M; Leavitt A; Tao Y; Gaziano JM; Stampfer MJ
J Natl Cancer Inst; 2004 Apr; 96(7):546-53. PubMed ID: 15069117
[TBL] [Abstract][Full Text] [Related]
16. Plasma insulin, IGF-binding proteins-1 and -2 and risk of colorectal cancer: a prospective study in northern Sweden.
Palmqvist R; Stattin P; Rinaldi S; Biessy C; Stenling R; Riboli E; Hallmans G; Kaaks R
Int J Cancer; 2003 Oct; 107(1):89-93. PubMed ID: 12925961
[TBL] [Abstract][Full Text] [Related]
17. Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts.
Wolpin BM; Michaud DS; Giovannucci EL; Schernhammer ES; Stampfer MJ; Manson JE; Cochrane BB; Rohan TE; Ma J; Pollak MN; Fuchs CS
Br J Cancer; 2007 Jul; 97(1):98-104. PubMed ID: 17533398
[TBL] [Abstract][Full Text] [Related]
18. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R
J Natl Cancer Inst; 2000 Dec; 92(23):1910-7. PubMed ID: 11106682
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays.
Rinaldi S; Kaaks R; Zeleniuch-Jacquotte A; Arslan AA; Shore RE; Koenig KL; Dossus L; Riboli E; Stattin P; Lukanova A; Toniolo P
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):48-52. PubMed ID: 15668475
[TBL] [Abstract][Full Text] [Related]
20. Increased circulating levels of insulin-like growth factor-I and decreased circulating levels of insulin-like growth factor binding protein-1 in postmenopausal women with endometrial cancer.
Ayabe T; Tsutsumi O; Sakai H; Yoshikawa H; Yano T; Kurimoto F; Taketani Y
Endocr J; 1997 Jun; 44(3):419-24. PubMed ID: 9279518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
